[HTML][HTML] Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis

O Menyhárt, B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
While cost-effective high-throughput technologies provide an increasing amount of data, the
analyses of single layers of data seldom provide causal relations. Multi-omics data …

Onco‐multi‐OMICS approach: a new frontier in cancer research

S Chakraborty, MI Hosen, M Ahmed… - BioMed research …, 2018 - Wiley Online Library
The acquisition of cancer hallmarks requires molecular alterations at multiple levels
including genome, epigenome, transcriptome, proteome, and metabolome. In the past …

Pediatrics consequences of caesarean section—a systematic review and meta-analysis

A Słabuszewska-Jóźwiak, JK Szymański… - International journal of …, 2020 - mdpi.com
Background: Cesarean section is a surgical procedure, which is the most frequently
performed in gynecology and obstetrics. It is commonly believed that an operative delivery is …

DNA methylation: conducting the orchestra from exposure to phenotype?

FAD Leenen, CP Muller, JD Turner - Clinical epigenetics, 2016 - Springer
Abstract DNA methylation, through 5-methyl-and 5-hydroxymethylcytosine (5mC and 5hmC),
is considered to be one of the principal interfaces between the genome and our …

Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation

BT Mayne, SY Leemaqz, AK Smith, J Breen… - …, 2017 - Taylor & Francis
Aim: To determine whether dynamic DNA methylation changes in the human placenta can
be used to predict gestational age. Materials & methods: Publicly available placental DNA …

Artificial intelligence to decode cancer mechanism: beyond patient stratification for precision oncology

SK Patel, B George, V Rai - Frontiers in Pharmacology, 2020 - frontiersin.org
The multitude of multi-omics data generated cost-effectively using advanced high-
throughput technologies has imposed challenging domain for research in Artificial …

Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers

M Ando, Y Saito, G Xu, NQ Bui… - Nature …, 2019 - nature.com
Although promoter-associated CpG islands have been established as targets of DNA
methylation changes in cancer, previous studies suggest that epigenetic dysregulation …

UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics

H Sidhu, N Capalash - Tumor biology, 2017 - journals.sagepub.com
UHRF1 is a master regulator of epigenome as it coordinates DNA methylation and histone
modifications. Compelling evidence suggests a strong link between UHRF1 overexpression …

Distinct chromatin signatures of DNA hypomethylation in aging and cancer

RF Perez, JR Tejedor, GF Bayon, AF Fernández… - Aging …, 2018 - Wiley Online Library
Cancer is an aging‐associated disease, but the underlying molecular links between these
processes are still largely unknown. Gene promoters that become hypermethylated in aging …

The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networks

M Ben Guebila, T Wang, CM Lopes-Ramos, V Fanfani… - Genome Biology, 2023 - Springer
Inference and analysis of gene regulatory networks (GRNs) require software that integrates
multi-omic data from various sources. The Network Zoo (netZoo; netzoo. github. io) is a …